A multicenter randomized clinical trial of portable transcranial alternating current stimulation for major depressive disorder
Authors:
Open Access
- 28 March 2026
- journal article
- Published by Springer Nature in npj Digital Medicine
- Vol. 9 (1)
Abstract
High-definition transcranial alternating current stimulation (HD-tACS) is an emerging neuromodulatory intervention for major depressive disorder (MDD). Here, we evaluate the efficacy and safety of a portable, low-intensity (1.6 mA), 10 Hz HD-tACS protocol targeting the bilateral dorsolateral prefrontal cortex (DLPFC) in adults with MDD. This randomized clinical trial was conducted including 120 adult MDD participants. Participants underwent 20 sessions (5 sessions/week for 4 weeks) of either active 10 Hz HD-tACS (1.6 mA) or sham stimulation a ratio of 1:1 and were followed for an additional 4 weeks. The primary outcome was the percentage reduction in 17-item Hamilton Depression Rating Scale scores at week 4. The active group showed significantly greater improvement in depression than the sham group (48% ± 14% vs 24% ± 13%, p < 0.001), sustained through the 4-week follow-up period. Additionally, significant improvements in the active group were also found in anxiety, sleep efficiency, quality of life components of physical, vitality, social functioning, and mental health. Adverse events including two cases of new-onset hypomania occurred, but no serious adverse events were observed. Thus, this trial supported the efficacy and good tolerability of 10 Hz HD-tACS for patients with MDD. Further research requires more focus on the underlying neural mechanisms and the optimized stimulation protocols. Trial Registration: China Clinical Trial Registry Identifier: ChiCTR2500103570. ClinicalTrials.gov Identifier: NCT06891326.Keywords
Funding Information
- Project supported by the Young Scientists Fund of the National Natural Science Fundation of China (82401813)
- Nursing Development Program of Shanghai Jiao Tong University School of Medicine (SJTUHLXK2022)
- 2024 Shanghai Ruijin Hospital Nursing Research Fund (RJHK-2024-001)
- 2024 Shanghai Nursing Association Research Fund (2024MS-B13)
- National Natural Science Foundation of China (82271515)
- National Natural Science Foundation of China (T2293730)
- Shanghai Municipal Science and Technology Major Project (2021SHZDZX)
This publication has 47 references indexed in Scilit:
- Transcranial Electrical Stimulation in Treatment of DepressionJAMA Network Open, 2025
- Transcranial alternating current stimulation (tACS): from basic mechanisms towards first applications in psychiatryEuropean Archives of Psychiatry and Clinical Neuroscience, 2020
- A systematic review and meta‐analysis on the effects of transcranial direct current stimulation in depressive episodesDepression and Anxiety, 2020
- Treatment Rate for Major Depressive Disorder in China: a Meta-Analysis of Epidemiological StudiesPsychiatric Quarterly, 2019
- Extending the parameter range for tDCS: Safety and tolerability of 4 mA stimulationBrain Stimulation, 2017
- Evaluation of a Modified High-Definition Electrode Montage for Transcranial Alternating Current Stimulation (tACS) of Pre-Central AreasBrain Stimulation, 2016
- Multimodal Approaches to Define Network Oscillations in DepressionBiological Psychiatry, 2015
- Alpha Power Increase After Transcranial Alternating Current Stimulation at Alpha Frequency (α-tACS) Reflects Plastic Changes Rather Than EntrainmentBrain Stimulation, 2015
- Antiphasic 40 Hz Oscillatory Current Stimulation Affects Bistable Motion PerceptionBrain Topography, 2013
- Efficacy and Safety of Transcranial Magnetic Stimulation in the Acute Treatment of Major Depression: A Multisite Randomized Controlled TrialBiological Psychiatry, 2007